Cite
MLA Citation
Amar Gajjar et al.. “Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).” Journal of clinical oncology, vol. 39, no. 7, 2021, pp. 822–835. http://access.bl.uk/ark:/81055/vdc_100170094706.0x000026